Loading...
Loading...
Bank of America upgraded Bruker Corporation
BRKR from Underperform to Neutral and raised the price objective from $15.00 to $19.50.
Bank of America noted, "Although we've been positive on BRKR's technology and long-term outlook, we've been cautious on shares chiefly due to the disappointing track record when it came to delivering on margin expansion, cash flow improvements, and profitability targets. While significant work remains, we are encouraged by the recent restructuring initiatives, which include hiring a new CFO and naming new operating group presidents. In addition, mgmt has shown a new willingness to reduce certain investments and prune unprofitable businesses, highlighting a renewed focus on not just growing, but growing profitably."
Bruker Corporation closed at $18.09 on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in